Literature DB >> 19704098

Prospective, comprehensive assessment of cardiac troponin T testing after coronary artery bypass graft surgery.

Asim A Mohammed1, Arvind K Agnihotri, Roland R J van Kimmenade, Abelardo Martinez-Rumayor, Sandy M Green, Rene Quiroz, James L Januzzi.   

Abstract

BACKGROUND: The significance and clinical role of cardiac troponin testing after coronary artery bypass grafting remain unclear. METHODS AND
RESULTS: Cardiac troponin T (cTnT) was measured during the first 24 hours after coronary artery bypass graft surgery in 847 consecutive patients. Only 17 patients (2.0%) had new Q waves or left bundle-branch block after surgery; however, cTnT elevation was observed in nearly all subjects, with a median cTnT concentration of 1.08 ng/mL overall. Direct predictors of postoperative cTnT values included preoperative myocardial infarction (P<0.001), preoperative intraaortic balloon pump (P<0.001), intraoperative/postoperative intraaortic balloon pump (P<0.001), number of distal anastomoses (P=0.005), bypass time (P<0.001), and number of intraoperative defibrillations (P=0.009), whereas glomerular filtration rate (P<0.001), off-pump coronary artery bypass grafting (P=0.003), and use of warm cardioplegia (P=0.02) were inversely associated with cTnT values. A linear association was seen between cTnT levels and length of stay and ventilator hours, and in an analysis adjusted for the Society for Thoracic Surgery Risk Model, cTnT remained independently prognostic for death (odds ratio, 3.20; P=0.003), death or heart failure (odds ratio, 2.04; P=0.008), death or need for vasopressors (odds ratio, 2.70; P<0.001), and the composite of all 3 (odds ratio, 2.57; P<0.001). In contrast to consensus-endorsed cTnT cut points for postoperative evaluation, a cTnT <1.60 ng/mL had a negative predictive value of 93% to 99% for excluding various post-coronary artery bypass graft surgery complications.
CONCLUSIONS: cTnT concentrations after coronary artery bypass graft surgery are nearly universally elevated, are determined by numerous factors, and are independently prognostic for impending postoperative complications when used at appropriate cut points.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19704098     DOI: 10.1161/CIRCULATIONAHA.108.837278

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  25 in total

Review 1.  Nrf2 at the heart of oxidative stress and cardiac protection.

Authors:  Qin M Chen; Anthony J Maltagliati
Journal:  Physiol Genomics       Date:  2017-11-29       Impact factor: 3.107

2.  Using next-generation RNA sequencing to examine ischemic changes induced by cold blood cardioplegia on the human left ventricular myocardium transcriptome.

Authors:  Jochen D Muehlschlegel; Danos C Christodoulou; David McKean; Joshua Gorham; Erica Mazaika; Mahyar Heydarpour; Grace Lee; Steven R DePalma; Tjorvi E Perry; Amanda A Fox; Stanton K Shernan; Christine E Seidman; Sary F Aranki; Jon G Seidman; Simon C Body
Journal:  Anesthesiology       Date:  2015-03       Impact factor: 7.892

3.  Postoperative complications after elective coronary artery bypass grafting surgery in patients with sleep-disordered breathing.

Authors:  Maria Tafelmeier; Teresa Weizenegger; Sarah Ripfel; Miriam Fauser; Bernhard Floerchinger; Daniele Camboni; York Zausig; Sigrid Wittmann; Marzena A Drzymalski; Florian Zeman; Christof Schmid; Lars S Maier; Stefan Wagner; Michael Arzt
Journal:  Clin Res Cardiol       Date:  2018-06-12       Impact factor: 5.460

4.  Predictive value of high-sensitivity troponin T in addition to EuroSCORE II in cardiac surgery.

Authors:  Liisa Petäjä; Helge Røsjø; Leena Mildh; Raili Suojaranta-Ylinen; Kirsi-Maija Kaukonen; Janne J Jokinen; Markku Salmenperä; Tor-Arne Hagve; Torbjørn Omland; Ville Pettilä
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-03-16

Review 5.  WITHDRAWN: Preoperative statin therapy for patients undergoing cardiac surgery.

Authors:  Elmar W Kuhn; Ingo Slottosch; Thorsten Wahlers; Oliver J Liakopoulos
Journal:  Cochrane Database Syst Rev       Date:  2016-05-24

6.  Diagnosis of MI after CABG with high-sensitivity troponin T and new ECG or echocardiogram changes: relationship with mortality and validation of the universal definition of MI.

Authors:  Tom Km Wang; Ralph Ah Stewart; Tharumenthiran Ramanathan; Nicholas Kang; Greg Gamble; Harvey D White
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-08-05

Review 7.  Diagnostic dilemma of perioperative myocardial infarction after coronary artery bypass grafting: A review.

Authors:  Viola Weidenmann; N Bryce Robinson; Lisa Q Rong; Irbaz Hameed; Ajita Naik; Mahmoud Morsi; Philippe Grieshaber; Andreas Böning; Leonard N Girardi; Mario Gaudino
Journal:  Int J Surg       Date:  2020-05-19       Impact factor: 6.071

8.  Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi-centre randomized double-blinded controlled clinical trial.

Authors:  Derek J Hausenloy; Luciano Candilio; Chris Laing; Gudrun Kunst; John Pepper; Shyam Kolvekar; Richard Evans; Steve Robertson; Rosemary Knight; Cono Ariti; Tim Clayton; Derek M Yellon
Journal:  Clin Res Cardiol       Date:  2011-12-21       Impact factor: 5.460

9.  Polymorphisms in glutathione S-transferase are risk factors for perioperative acute myocardial infarction after cardiac surgery: a preliminary study.

Authors:  Viktória Kovacs; Balazs Gasz; Borbala Balatonyi; Luca Jaromi; Peter Kisfali; Balazs Borsiczky; Gabor Jancso; Nandor Marczin; Sandor Szabados; Bela Melegh; Alotti Nasri; Elisabeth Roth
Journal:  Mol Cell Biochem       Date:  2014-01-17       Impact factor: 3.396

10.  The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction.

Authors:  Bernard R Chaitman; Regina M Hardison; Dale Adler; Suzanne Gebhart; Mary Grogan; Salvador Ocampo; George Sopko; Jose A Ramires; David Schneider; Robert L Frye
Journal:  Circulation       Date:  2009-11-17       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.